No Data
No Data
William Blair Sticks to Its Buy Rating for Cabaletta Bio (CABA)
Cabaletta Bio Unveils Updated Corporate Strategy Details
Express News | Cabaletta Bio Shares Are Trading Lower. The Company Reported Q2 Financial Results
Cabaletta Bio | 10-Q: Quarterly report
Express News | Cabaletta Bio: Cash, Cash Equivalents & Short-Term Investments as of June 30, 2024 Expected to Support Operations Into H1 2026
Cabaletta Bio: Runway to Support Operations Into 1st Half of 2026 >CABA
No Data
diamonds : Excuse me, can shares held still be valid after ENDPQ's restructuring?